Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Shaw AT, Kim TM, Crinò L. et al.
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.

Lancet Oncol 2017;
18 (07) 874-886

Bibliographische Angaben herunterladen

Aufrufen in: